IDH2 and acute myeloid leukemia: One article [21] reported the median OS of IDH inhibitor combination therapy in patients with newly diagnosed IDH-mutated AML and one article [29] reported the median OS of IDH inhibitor monotherapy in patients with newly diagnosed IDH-mutated AML.